Capvizr
THE DEAL, AT A GLANCE

Zymergen

From the announcement
01Who is involvedBacked by Various (IPO)From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedZymergen raised $500M IPOFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersZymergen's IPO financing supports a product and platform thesis: launch Hyaline electronic film product while scaling an AI-powered biofoundry for material and chemical…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Zymergen · Financing Record

Explore source-linked visual explanations for Zymergen. Unsupported claims are withheld while source review continues.

Record 467 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 467 →

Open record 666 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime